Product Information
AMPHETAMINE ER 12.5 MG ODT is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $16.2480 per EA under NDC 00480331865. Its NADAC has been published 30 times since Jan 28, 2026.
FDA first approved this application on Jun 22, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480331865
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA209253FDA Approved
6/22/2023
TE Code
AB
On Market Since
12/8/2025
Pharmacological Classes
Price Statistics
The NADAC for AMPHETAMINE ER 12.5 MG ODT has been published 30 times since Jan 28, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.2480 per EA |
|---|---|
| All-time high | $16.5820 (Apr 15, 2026) |
| All-time low | $16.2480 (Aug 19, 2026) |
| 52-week high | $16.5820 |
| 52-week low | $16.2480 |
| Median price | $16.5570 |
| Average price | $16.4578 |
| Largest weekly change | -0.8% (May 20, 2026) |
| Weeks tracked | 30 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMPHETAMINE ER 12.5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for AMPHETAMINE ER 12.5 MG ODT, manufactured by Teva Pharmaceuticals USA Inc., is $16.2480 per EA (NDC 00480331865), effective Aug 19, 2026.
How has the price of AMPHETAMINE ER 12.5 MG ODT changed over time?
Over the history we have for it, the NADAC for AMPHETAMINE ER 12.5 MG ODT has held within roughly two percent of its current level. It has been tracked across 30 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for AMPHETAMINE ER 12.5 MG ODT?
Since Jan 28, 2026, the NADAC for AMPHETAMINE ER 12.5 MG ODT has ranged from a low of $16.2480 (Aug 19, 2026) to a high of $16.5820 (Apr 15, 2026), with a median of $16.5570 per EA.
Are there cheaper alternatives to AMPHETAMINE ER 12.5 MG ODT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMPHETAMINE ER 12.5 MG ODT in a comparable dosage form, but none are currently priced below it.
Who manufactures AMPHETAMINE ER 12.5 MG ODT?
AMPHETAMINE ER 12.5 MG ODT (NDC 00480331865) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.